GrowingStockReport.com

Xyratex Ltd. (NASDAQ:XRTX) and Medivation, Inc. (NASDAQ:MDVN) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 

New York, NY -- (ReleaseWire) -- 04/05/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Xyratex Ltd. (NASDAQ:XRTX) and Medivation, Inc. (NASDAQ:MDVN).

Xyratex Ltd. (NASDAQ:XRTX) a company that provides modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry is currently up (+3.51%) on 444,417 shares traded after Xyratex Ltd Announced Results for the First Quarter Fiscal Year 2013. Xyratex Ltd. (NASDAQ:XRTX) is currently up (+59.34%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Xyratex Ltd. (NASDAQ:XRTX)

Medivation, Inc. (NASDAQ:MDVN) a biopharmaceutical company that focuses on development and commercialization of novel therapies to treat serious diseases in the United States is currently up (+4.98%) on 1,520,734 shares traded after MEDIVATION, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits. Medivation, Inc. (NASDAQ:MDVN) is currently up (+43.09%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Medivation, Inc. (NASDAQ:MDVN)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com